News and Analysis Stämm rakes in $17m Series A Stämm, a biotechnology company, has raised $17 million in Series A funding. Iris Dorbian - 17 March 2022 Share A- A+ 100% Create an account to continue reading Gain instant access to our expert editorial analysis and in-depth insight. Register for free Already have an account? Sign in